IP Library › Granted Patent US 10,689,629
Granted Patent B1
US 10,689,629 · App. 16/210,608 · Granted Jun 23, 2020

Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands

Inventors: Igor V. Kutyavin (Woodinville, WA); Sergey G. Lokhov (Bothell, WA)
Assignee: Cepheid
C12N9/1252C12N15/115C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,689,629
App. No.
16/210,608
Granted
Jun 23, 2020
Kind
B1
Abstract

Provided are methods and compositions for activating oligonucleotide aptamer-deactivated DNA polymerases, comprising cleaving the aptamer by endonuclease V enzymatic activity to reduce or eliminate binding of the oligonucleotide aptamer to the DNA polymerase, thereby activating DNA synthesis activity of the DNA polymerase in a reaction mixture. Mixtures for use in methods of the invention are also provided. The oligonucleotide aptamers of the present invention are circular and comprise one or more deoxyinosine nucleotides providing for aptamer-specific recognition and cleavage of the circular aptamer by the endonuclease V enzymatic activity. Exemplary oligonucleotide aptamers, mixtures and methods employing endonuclease V enzymatic activity are provided. The methods can be practiced using kits comprising a DNA polymerase-binding oligonucleotide aptamer and at least one endonuclease V enzymatic activity having oligonucleotide aptamer-specific recognition to provide for specific cleavage of the aptamer by the endonuclease V enzymatic activity.

Claims (18)

1. A method of activating an aptamer-inactivated DNA polymerase, comprising:

providing a reaction mixture suitable for DNA synthesis, the reaction mixture comprising (i) a DNA polymerase, (ii) an endonuclease V-cleavable circular oligonucleotide aptamer that binds to the DNA polymerase, wherein the oligonucleotide aptamer is present in an amount effective to inhibit DNA synthesis activity of the DNA polymerase in the reaction mixture, and (iii) an endonuclease V enzymatic activity; and

cleaving the aptamer by the endonuclease V enzymatic activity to reduce or eliminate binding of the oligonucleotide aptamer to the DNA polymerase, thereby activating the DNA synthesis activity of the DNA polymerase, to increase DNA synthesis in the reaction mixture.

2. The method of claim 1 , wherein said cleaving is facilitated using a reaction temperature that facilitates both DNA polymerase activity and the endonuclease V enzymatic activity.

3. The method of claim 1 , wherein said cleaving is facilitated by increasing the temperature of the reaction mixture from a first temperature to a second temperature that more strongly facilitates the endonuclease V enzymatic activity.

4. The method of claim 1 , wherein said providing comprises dissolving a dried form of at least one of said (i) DNA polymerase, (ii) endonuclease V-cleavable circular oligonucleotide aptamer, and (iii) endonuclease V enzymatic activity into an aqueous solution.

5. The method of claim 1 , wherein the DNA synthesis results in DNA amplification in the reaction mixture.

6. The method of claim 5 , wherein the DNA amplification is an isothermal amplification reaction.

7. The method of claim 5 , wherein the DNA amplification comprises PCR.

8. The method of claim 5 , comprising detecting the presence of a target DNA in the reaction mixture.

9. The method of claim 5 , comprising measuring an amount of a target DNA in the reaction mixture.

10. The method of claim 1 , wherein the circular oligonucleotide aptamer comprises one or more deoxyinosine nucleotides.

11. The method of claim 10 , wherein the circular oligonucleotide aptamer has a stem-loop structure.

12. The method of claim 11 , wherein the one or more deoxyinosine nucleotides are incorporated into the stem segment of the stem-loop structure.

13. The method of claim 11 , wherein the one or more deoxyinosine nucleotides are incorporated into the loop segment of the stem-loop structure.

14. The method of claim 13 , wherein the loop of the stem-loop structure, comprises a nucleotide sequence selected from the group consisting of 5′-TTCITAGCGTTT-3′ (SEQ ID NO:19), 5′-TTCTIAGCGTTT-3′ (SEQ ID NO:20), 5′-TTCTTAICGTTT-3′ (SEQ ID NO:21), 5′-TTCIIAGCGTTT-3′ (SEQ ID NO:22), 5′-TTCITAICGTTT-3′ (SEQ ID NO:23), 5′-TTCTIAICGTTT-3′ (SEQ ID NO:24), and 5′-TTCIITAICGTTT-3′ (SEQ ID NO:25).

15. The method of claim 14 , wherein the loop of the stem-loop structure comprises one of the nucleotide sequences 5′-TTCITAGCGTTT-3′ (SEQ ID NO:19), 5′-TTCTIAGCGTTT-3′ (SEQ ID NO:20), or 5′-TTCTTAICGTTT-3′ (SEQ ID NO:21).

16. The method of claim 1 , wherein the endonuclease V enzymatic activity comprises Thermotoga maritima endonuclease V enzymatic activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2019
From: KUTYAVIN, IGOR V.; LOKHOV, SERGEY G.
To: CEPHEID
Reel/Frame 048063/0423 →
Continuity (1)
Provisional Application 62595453 · Dec 6, 2017
Cited By (1)
US 12,385,045